a complete remission rate of 82 % was obtained in a group of 68 patients with acute myelogenous leukemia treated with a high-dose induction chemotherapy ( tad ) consisting of 7-day courses of 6-thioguanine , cytarabine , and daunorubicin .
C0023467
acute myelogenous leukemia
C0011015
daunorubicin